You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

CLINICAL TRIALS PROFILE FOR LY3871801

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for LY3871801

Show entries

Subscribe to access the full database, or Try for Free
Trial ID	Title	Status	Sponsor	Phase	Summary

NCT05222399 ↗	A Study of LY3871801 in Healthy Participants	Not yet recruiting	Eli Lilly and Company	Phase 1	The main purpose of this study is to compare the amount of LY3871801 that gets into the blood stream and how long it takes the body to get rid of it, when given as crystalline freebase tablet (test) and as a solid dispersion oral suspension (reference) in healthy participants. The information about any adverse effects experienced will be collected and the tolerability of LY3871801 will also be evaluated. The study may last up to approximately 15 days excluding the 28 days of screening period.
NCT05602675 ↗	A Drug Interaction Study of LY3871801 in Healthy Participants	Not yet recruiting	Eli Lilly and Company	Phase 1	The main purpose of this study is to determine the effect of LY3871801 when administered orally on the levels of methotrexate (part 1), drug cocktail (warfarin, dextromethorphan, and midazolam) and repaglinide (part 2) in the blood stream when administered orally in healthy participants. The information about any adverse effects experienced will be collected and the tolerability of LY3871801 will also be evaluated. The study may last up to approximately 25 days for each participant.
NCT05848258 ↗	An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis	Not yet recruiting	Rigel Pharmaceuticals	Phase 2	The main purpose of this study is to evaluate the efficacy and safety of LY3871801 in adult participants with active moderately-to-severe rheumatoid arthritis (RA).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Showing 1 to 3 of 3 entries

Clinical Trial Conditions for LY3871801

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Healthy	4
Rheumatoid Arthritis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Arthritis	1
Arthritis, Rheumatoid	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LY3871801

Trials by Country

Map
Table

+

−

Trials by Country
Location	Trials
France	8
Mexico	7
United States	6
Germany	5
United Kingdom	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

+

−

Trials by US State
Location	Trials
California	2
Wisconsin	1
North Carolina	1
Florida	1
Texas	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LY3871801

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 2	1
Phase 1	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Not yet recruiting	3
Completed	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LY3871801

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Eli Lilly and Company	5
Rigel Pharmaceuticals	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.